Matrix Metalloproteinase (MMP) Inhibition Selectively Decreases Type II MMP Activity in a Murine Model of Pancreatic Cancer
- 31 January 1999
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 81 (1) , 65-68
- https://doi.org/10.1006/jsre.1998.5447
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Matrix Metalloproteinase Inhibition Attenuates Human Pancreatic Cancer Growthin Vitroand Decreases Mortality and Tumorigenesisin VivoJournal of Surgical Research, 1997
- Pancreaticoduodenectomy for Cancer of the Head of the Pancreas 201 PatientsAnnals of Surgery, 1995
- Current Management of Pancreatic CarcinomaAnnals of Surgery, 1995
- Proteolytic remodeling of extracellular matrixCurrent Opinion in Cell Biology, 1995
- Protease inhibitors: Role and potential therapeutic use in human cancerEuropean Journal Of Cancer, 1994
- Tumor Cell Interactions with the Extracellular Matrix During Invasion and MetastasisAnnual Review of Cell Biology, 1993
- Type IV collagenases in invasive tumorsBreast Cancer Research and Treatment, 1993
- Association Between Expression of Activated 72-Kilodalton Gelatinase and Tumor Spread in Non-Small-Cell Lung CarcinomaJNCI Journal of the National Cancer Institute, 1993
- The architecture of cancer.BMJ, 1992
- Correlation between collagenolytic activity and grade of histological differentiation in colorectal tumorsInternational Journal of Cancer, 1990